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Persistent ovarian follicles and
associated elevated concentrations
of estradiol which develop during
progestin-based estrous synchrony
programs are not detrimental to
fertility if persistent ovarian fol-
licles are not allowed to ovulate.
Summary
Following treatments causing ei-
ther prolonged elevated concentrations
of estradiol associated with develop-
ment of persistent follicles or inhibited
elevated concentrations of estradiol
and development of persistent follicles,
conception rates were compared. Beef
females received either four norges-
tomet implants for 9 days (day 0 =
treatment initiation; n=59) or one
norgestomet implant for 7 days and
three additional norgestomet implants
for 2 days (n=60). All implants were
removed on day 9 followed by estrous
detection and AI for 7 days. Treatment
and day interacted to affect estradiol
concentrations from day 0 to day 9 with
elevated estradiol in females treated
with one norgestomet implant for 7
days. Conception rates to AI were simi-
lar across treatments. Prolonged ele-
vated concentrations of estradiol
associated with development of persis-
tent ovarian follicles do not affect fer-
tility when persistent ovarian follicles
are not allowed to ovulate.
Introduction
Cattle treated with commercial doses
of synthetic progestins, such as
melengestrol acetate and norgestomet
or small doses of progesterone in the
absence of corpora lutea, often develop
persistent ovarian follicles. These fol-
licles develop because of greater LH
pulse frequency than naturally occurs
during the luteal phase which, in turn,
promotes prolonged development of the
dominant follicle and increased con-
centrations of estradiol.
Reduced fertility is associated with
estrus and mating following develop-
ment and ovulation of persistent ova-
rian follicles. This fertility reduction
may be due to adverse effects of pro-
longed elevation of estradiol on the
reproductive tract, compromised oo-
cyte development in persistent ovarian
follicles or a combination of these fac-
tors.
The objectives of this study were to
compare conception rates and time to
estrus in cattle following treatments
designed to: 1) inhibit persistent ova-
rian follicle development and elevated
concentrations of estradiol; or 2) cause
development of persistent ovarian fol-
licles and prolonged elevated concen-
trations of estradiol, but inhibit ovulation
of the follicles.
Procedure
Heifers (n=80) and 2-year-old
MARC III (1/4 Angus, 1/4 Red Poll,
1/4 Pinzgauer, 1/4 Hereford) cows
(n=39) from the beef physiology herd
were injected twice with PGF2α (25 mg;
Lutalyse® Sterile Solution, Upjohn,
Kalamazoo, MI) 11 days apart. The last
injection occurred on the day of treat-
ment initiation to destroy the function
of existing corpora lutea and synchro-
nize the estrous cycle stage prior to
experiment. All females exhibiting
estrus were 6 to 8 days post-estrus at
treatment initiation. Females were strati-
fied by age, blocked by estrual status
(previously exhibited estrus or anestrus)
and assigned to receive either: 1) four
norgestomet implants (4 Norg; n=59;
hydron implant with 6 mg norgestomet;
Sanofi Animal Health Inc., Overland
Park, KS) for 9 days (day 0 = treatment
initiation); or 2) one norgestomet im-
plant from day 0 to day 7 and three
additional norgestomet implants from
day 7 to day 9 (1+3 Norg; n=60). All
females received an injection of PGF2α(25 mg) at treatment initiation and all
implants were removed on day 9.
Females were observed for signs of
behavioral estrus every 6 hours from
time of implant removal (day 9) until
day 16 with the aid of K-Mar devices
and epididymal ligated bulls. Females
exhibiting estrus were bred by AI 6 to
12 hours following estrus detection.
Blood samples were collected daily
from treatment initiation (day 0) until
the end of estrous detection and AI (day
16) and twice weekly for an additional
30 days thereafter. While concentra-
tions of progesterone were determined
in all samples collected, concentrations
of estradiol were determined only in
samples collected from day 0 to day 16.
Females were considered pregnant
when, following breeding, concentra-
tions of progesterone increased to above
2 ng/ml of serum and remained at con-
centrations characteristic of normal
luteal function until termination of the
experiment. Uterine ultrasonography
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approximately 35 days following AI
was to confirm the progesterone pro-
files to determine if pregnancy occurred
as a result of AI.
Results
There was a treatment x day interac-
tion (P < .01) for concentrations of
estradiol from day 0 to day 9 of the
experiment, with elevated estradiol oc-
curring in females receiving the 1+3
Norg treatment (Figure 1). The increase
in concentration of estradiol from day 0
to day 7 in females treated with 1+3
Norg was indicative of persistent ova-
rian follicle development and the acute
decline in estradiol observed after treat-
ment with three additional norgestomet
implants was indicative of induced atre-
sia of persistent follicles. Concentra-
tion of progesterone in females of both
treatment groups declined from day 0 to
day 1 in response to PGF2α injected on
day 0 and remained low through day 9
of the experiment.
Estrous synchronization rate (num-
ber in estrus/number in treatment group)
and pregnancy rate (number conceived
to AI/number in treatment group) were
affected (P < .10) by treatment x estrual
status. Estrous synchronization rate of
estrual females did not differ between
treatment groups (Table 1). There was
a greater percentage (P < .10) of previ-
ously anestrus females displaying signs
of estrus within 7 days after removal of
norgestomet implants in the 4 Norg
group (97 %) as compared with the 1+3
Norg group (67 %). Age, estrual status,
treatment x age and treatment x estrual
status affected neither conception rates
nor time to onset of behavioral estrus
after removal of norgestomet implants.
Conception rates (number conceived/
number inseminated) to AI were not
different among females treated with
1+3 Norg (72%) and those treated with
4 Norg (67%). Pregnancy rates of both
estrual and anestrous females did not
differ between treatment groups (Table
1). Mean time from norgestomet with-
drawal to behavioral estrus was longer
(P < .001) in females treated with 1+3
Norg (105 hours) than with females
treated with 4 Norg (61 hours).
Using two different protocols of syn-
thetic progestin treatment, elevated
concentrations of estradiol associated
with development of persistent ovarian
follicles were unable to affect concep-
tion rate to AI. Results indicate similar
conception rates can be achieved in
cattle in which progestin treatment al-
lows a persistent ovarian follicle to
develop and subsequently causes its
regression, as compared with cattle in
which larger doses of synthetic proges-
tin treatment prohibit the development
of persistent ovarian follicles. It ap-
pears that allowing persistent ovarian
follicles and their associated elevated
concentrations of estradiol to develop
is not detrimental to fertility when the
follicle is regressed before the ovula-
tory follicle associated with pregnancy
ovulates. Conclusions drawn from this
and other studies indicate decreased
pregnancy rates observed in associa-
tion with ovulation of a persistent ova-
rian follicle are likely due to abnormal
maturation of the oocyte rather than
effects of elevated concentrations of
estradiol on oviductal or uterine func-
tion.
Because we induced regression of
the persistent ovarian follicles by treat-
ment with three additional norgestomet
implants, we also shortened the dura-
tion of elevated concentrations of estra-
diol when compared with the duration
in cattle ovulating persistent ovarian
follicles. In cattle receiving the 1+3
Norg treatment, there was a 105 hour
interval from time of removal of
norgestomet implants until the onset of
estrus; cows treated with 4 norgestomet
implants had a 61 hour interval. It is
possible lesser concentrations of
Figure 1. Concentrations of estradiol in circulation from day 0 to 16 of the experiment of
females during treatment with either four norgestomet implants for 9 days (4 Norg) or one
norgestomet for 7 days followed by an additional three implants for 2 days (1+3 Norg).
Arrows indicate day of insertion of 3 norgestomet implants in 1+3 Norg treatment group
and day of removal of all implants for both treatment groups. There is a treatment x day
interaction (P < .01) from day 0 to 9 of the experiment.
(Continued on next page)
Table 1. Estrous synchrony rates, conception
and pregnancy rates to AI and time to
behavioral estrus of females treated
with 1+3 Norg or 4 Norg implants
Treatment
4 Norg 1+3 Norg
Estrous synchronya (%)
Estrual 97 100
Anestrous 97† 67
Conception Rate (%) 67 72
Pregnancy Ratea (%)
Estrual 66 77
Anestrous 63 43
Time to estrus (hours) 61*** 105
†P < .10
***P < .001
aThere was a treatment x estrual status interaction
(P < .10), therefore animals that were estrual and
anestrous were analyzed separately.
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circulating estradiol from the time of
induced regression of the persistent ova-
rian follicle until preovulatory follicle
development allowed for oviductal and
uterine function to return to normal
before the oocyte/embryo entered the
reproductive tract. The extended inter-
val from treatment withdrawal to onset
of estrus may be due to an acute reduc-
tion in LH pulse frequency resulting
from treatment with three norgestomet
implants. It is likely treatment with the
three additional norgestomet implants
caused an immediate decrease in the
frequency of LH pulses, induced atresia
of the persistent ovarian follicle and
delayed development of the next domi-
nant follicle. Dominant persistent ova-
rian follicles suppress development of
subordinate follicles; therefore, it is
plausible that, in females treated with
1+3 Norg, subordinate follicles were
smaller resulting from the presence of
persistent ovarian follicles and thus re-
quired more time to develop to ovula-
tion.
The present study provides evidence
that estrous synchrony programs based
on treatment with doses of commer-
cially used synthetic progestins will not
result in compromised fertility at the
synchronized estrus if persistent ova-
rian follicles are regressed before the
ovulatory follicle associated with preg-
nancy is allowed to ovulate. Develop-
ment of future estrous synchrony
programs using small doses of progestins
should focus on allowing for ovulation
of typically growing dominant follicles
or using larger doses of progestins to
inhibit development of persistent ova-
rian follicles.
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